Related Entities
Volcano Corp announces 1st human use of Volcano optical catheter
1 articles also mentioned Scott Huennekens
Volcano Corp announces 1st human use of Volcano optical catheter
1 articles also mentioned Christopher E. Banas
Volcano Corp announces 1st human use of Volcano optical catheter
1 articles also mentioned CardioSpectra
Volcano Corp announces 1st human use of Volcano optical catheter
1 articles also mentioned Volcano
Volcano Corp announces 1st human use of Volcano optical catheter
1 articles also mentioned Patrick W. Serruys
Volcano Corp announces 1st human use of Volcano optical catheter
1 articles also mentioned Thoraxcenter at Erasmus University Medical Center
About Michel Lussier
Michel E. Lussier, President, Volcano Europe and Clinical and Scientific Affairs. Michel E. Lussier has served as Managing Director of Volcano Europe since March 2006. From July 2002 to March 2006, Mr. Lussier served as our Vice President, General Manager of Europe, Africa and Middle East Operations. In February 2002, Mr. Lussier founded MedPole S.A./N.V., a European distribution incubator for medical device start up companies located in Brussels. From October 1998 to January 2002, Mr. Lussier served as the Vice President and General Manager, Europe of Novoste Corp., a medical technology company. Mr. Lussier holds a B.S. in Electrical Engineering and an M.S. in Biomedical Engineering from the University of Montreal and an M.B.A. from INSEAD.
Quotes
-
“ The high resolution OCT images provide a glimpse at structural detail not seen before by other imaging modalities. We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs. ”
In Volcano Corp announces 1st human use of Volcano optical catheter -
“ The high resolution OCT images provide a glimpse at structural detail not seen before by other imaging modalities. We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs. Volcano is committed to exploring the various clinical benefits of our OCT platform through detailed data-driven study design and mutually beneficial partnerships with other therapy companies. ”
In Volcano Corp Announces First Human Use of the Volcano Optical ...






Recent Comments
Eric Swanson » The Evolution of Spectral Domain OCT
For more information see http://octnews.hivefire.com/entity/profile/oct-information-on-ophthalmology-website/
bernie » Morphology and Epidermal Thickness of Normal Skin Imaged by Optical Coherence Tomography.
Interesting
See all recent comments